A Randomized, Double-blind, Parallel, Nested Crossover Study to Investigate the Effect of Albiglutide on Cardiac Repolarization (Corrected QT Interval) Compared With Placebo in Healthy Male and Female Subjects: A Thorough ECG Study Employing Placebo, Albiglutide, and a Positive Control (Moxifloxacin).
Phase of Trial: Phase I
Latest Information Update: 12 Jun 2017
At a glance
- Drugs Albiglutide (Primary) ; Moxifloxacin
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- Sponsors GlaxoSmithKline
- 06 Jan 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 07 Oct 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 28 Jul 2011 New trial record